खोज परिणाम - Pedroncelli, Alberto M

  • प्रदर्शित 1 - 9 परिणाम 9
परिणाम को परिष्कृत करें
  1. 1
    Pasireotide treatment significantly reduces tumor volume in patients with Cushing’s disease: results from a Phase 3 study

    Pasireotide treatment significantly reduces tumor volume in patients with Cushing’s disease: results from a Phase 3 study द्वारा Lacroix, André, Gu, Feng, Schopohl, Jochen, Kandra, Albert, Pedroncelli, Alberto M., Jin, Lixian, Pivonello, Rosario

    प्रकाशित 2019
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  2. 2
    Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

    Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly द्वारा Schmid, Herbert A., Brue, Thierry, Colao, Annamaria, Gadelha, Mônica R., Shimon, Ilan, Kapur, Karen, Pedroncelli, Alberto M., Fleseriu, Maria

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  3. 3
    Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study

    Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study द्वारा Findling, James W., Fleseriu, Maria, Newell-Price, John, Petersenn, Stephan, Pivonello, Rosario, Kandra, Albert, Pedroncelli, Alberto M., Biller, Beverly M. K.

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  4. 4
    Long-Term Control of Urinary Free Cortisol With Osilodrostat in Patients With Cushing’s Disease: Final Results From the LINC 2 Study

    Long-Term Control of Urinary Free Cortisol With Osilodrostat in Patients With Cushing’s Disease: Final Results From the LINC 2 Study द्वारा Fleseriu, Maria, Biller, Beverly M K, Bertherat, Jerome, Young, Jacques, Arnaldi, Giorgio, O’Connell, Paul, Izquierdo, Miguel, Pedroncelli, Alberto M, Pivonello, Rosario

    प्रकाशित 2021
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  5. 5
    Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

    Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study द्वारा Samson, Susan L., Gu, Feng, Feldt-Rasmussen, Ulla, Zhang, Shaoling, Yu, Yerong, Witek, Przemysław, Kalra, Pramila, Pedroncelli, Alberto M., Pultar, Philippe, Jabbour, Nadine, Paul, Michaela, Bolanowski, Marek

    प्रकाशित 2021
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  6. 6
    Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

    Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study द्वारा Colao, Annamaria, Bronstein, Marcello D, Brue, Thierry, De Marinis, Laura, Fleseriu, Maria, Guitelman, Mirtha, Raverot, Gerald, Shimon, Ilan, Fleck, Jürgen, Gupta, Pritam, Pedroncelli, Alberto M, Gadelha, Mônica R

    प्रकाशित 2020
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  7. 7
    Risk factors and management of pasireotide-associated hyperglycemia in acromegaly

    Risk factors and management of pasireotide-associated hyperglycemia in acromegaly द्वारा Gadelha, Mônica R, Gu, Feng, Bronstein, Marcello D, Brue, Thierry C, Fleseriu, Maria, Shimon, Ilan, van der Lely, Aart J, Ravichandran, Shoba, Kandra, Albert, Pedroncelli, Alberto M, Colao, Annamaria A L

    प्रकाशित 2020
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  8. 8
    Osilodrostat Is an Effective and Well-Tolerated Treatment for Cushing’s Disease (CD): Results From a Phase III Study With an Upfront, Randomized, Double-Blind, Placebo-Controlled Phase (LINC 4)

    Osilodrostat Is an Effective and Well-Tolerated Treatment for Cushing’s Disease (CD): Results From a Phase III Study With an Upfront, Randomized, Double-Blind, Placebo-Controlled P... द्वारा Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Hofstetter, Georg, Pedroncelli, Alberto M, Snyder, Peter J

    प्रकाशित 2021
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  9. 9
    Randomized Trial of Osilodrostat for the Treatment of Cushing Disease

    Randomized Trial of Osilodrostat for the Treatment of Cushing Disease द्वारा Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Yu, Yerong, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Pedroncelli, Alberto M, Snyder, Peter J

    प्रकाशित 2022
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:

खोज साधन: